Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
csjj up 28.5% today =o)
tried to buy yesterday @.0025 wouldn't fill. so ill ride my 200000 fwiw
fgwce news posted earlier by trsturgut-18 http://investorshub.com/boards/read_msg.asp?message_id=3122113
its about time for that one to bust out. thx
biph up 21%+ agrd 11% seho down 15% but not for long.
nice huh? still has that momo.
oh, missed that one. that e through me off! lol
this is my one long. just gonna cash in after the BIG runs.
ITFI chart, i can see it heading north soon.
biph-news,seho-chart, and agrd reversal.
yep, thats what i figured, i dont know why dallas was getting adds. must be a glitch.
it is a no moderator board. started by a freeby user. noticed you have the same adds though.
must be standard ihub free board policy.
new board for believers to share stock picks. http://investorshub.com/boards/board.asp?board_id=2556
new board for believers to share stock picks. http://investorshub.com/boards/board.asp?board_id=2556
new board for believers to share stock picks. http://investorshub.com/boards/board.asp?board_id=2556
new board for believers to share stock picks. http://investorshub.com/boards/board.asp?board_id=2556
new board for believers to share stock picks. http://investorshub.com/boards/board.asp?board_id=2556
new board for believers to share stock picks. http://investorshub.com/boards/board.asp?board_id=2556
new board for believers to share stock picks. http://investorshub.com/boards/board.asp?board_id=2556
it would be pretty hard to stir anything here. hope you have a good game like the last one. still got you bookmarked! good luck babycakes.
should get a boost from fridays news.http://investorshub.com/boards/read_msg.asp?message_id=3089249
So, what stocks are hot with Gods people?
somewhere in that book there is something about his hair. but anyway for a jew of his time long hair would not have been cool. how have you been babycakes?
wanna bet? lol.
bpa, still smokin!
man that BPA sure has been rockin the house!
i knew you would come around. =o)
workin my kahunas off! very busy, havent had enough time to even trade much. you?
im in!
Biophan Announces Development of Breakthrough Long-Life Biothermal Battery
5/14/2004 4:01:00 PM
Company Acquires Majority Interest in Biothermal Battery Nanotechnology Venture Targeting Approximately $500 Million Global Market
ROCHESTER, N.Y., May 14, 2004 (BUSINESS WIRE) -- Biophan Technologies, Inc. ( BIPH ), a leading developer of next generation biomedical technology, announced today that it has acquired a majority interest in TE-Bio, LLC, a company developing a breakthrough, long-life power source for use in implanted medical devices, such as pacemakers, defibrillators, neurostimulators, and drug pumps.
The technology is based on a patented innovation in the utilization of thermoelectric materials, using nanoscale-based, thin-film materials to convert thermal energy produced naturally by the human body into electrical energy. The resulting power can be used to "trickle charge" batteries for medium-power devices such as defibrillators, or directly power low-energy devices like pacemakers. The Company will be displaying the technology to over 6,000 healthcare professionals at the NASPE--Heart Rhythm Society's Heart Rhythm 2004 Conference, May 19-22, 2004 in San Francisco, CA.
TE-Bio is developing an implantable power system that has the potential to provide as much as a 30-year life--a five-fold increase in service life compared to existing technology. The technology is anticipated to dramatically extend the service life of neurostimulators and drug pumps that are used for treatment of tremors, diabetes, and chronic pain. Furthermore, since these devices can be implanted in young patients, the combination of TE-Bio technology and extended device life may reduce the number of replacement implants needed throughout a patient's life. For further information or to view the patent, please visit www.biophan.com/biothermal.php.
The use of implantable electronic medical devices is increasing worldwide due, in part, to the aging of the population and the increased use of these devices for both diagnostic and therapeutic treatments. However, existing systems share a major shortcoming - the need for a reliable electrical power source that does not require periodic surgical removal and replacement. Virtually all medical devices require replacement. It is estimated that neurostimulators, used to treat Parkinson's disease, last an average of three years; defibrillators last about five to six years, and pacemakers an average of about eight years.
Thermoelectric materials are special types of semiconductors that produce electricity when one side of the material is heated and the other is cooled. These materials have been used to generate electricity on spacecraft, such as the Voyager space probe, that are too far away from the sun for solar cells to operate. However, the low energy efficiency of existing materials has required very large temperature differences to produce a sufficient amount of usable power.
Recent advances in nanotechnology have now made new thermoelectric materials with the potential for generating sufficient electrical power for implantable medical devices, in part due to the ability to produce many more semiconductors on a surface.
TE-Bio holds a worldwide exclusive license to patent #6,640,137 "Biothermal Power Source for Implantable Devices" from Biomed Solutions, LLC.
"The realization of generating enough energy to power a pacemaker, or extend the life of a defibrillator, from the heat differential in our bodies, has been brought within striking distance by the remarkable revolution in materials science and advances in nanotechnology," stated Michael Weiner, CEO of Biophan.
Conference Call and Webcast
The Company will discuss the impact and market opportunity represented by this breakthrough technology on a conference call and webcast on Tuesday, May 18 at 12:00 pm Eastern. Following the discussion, Michael Weiner, president of Biophan, and other members of the executive management team will be available to answer questions regarding the technology and other technology which the Company is currently developing. Participants may ask questions during the Q & A segment of the call or, if they prefer, may e-mail questions in advance of the call to Randy Lewis, senior vice president of Trilogy Capital Partners, randy@trilogy-capital.com. To access the call, Investors should call at (888) 423-3274, code 731878 or from an international location by calling (651) 291-0278.
About Biophan Technologies
Biophan Technologies develops and markets cutting-edge technologies designed to make biomedical devices--such as cardiac pacemakers, surgical and diagnostic tools--safe and compatible with magnetic resonance imaging (MRI) equipment. The Company develops enabling technologies for implanted medical systems such as pacemakers, and interventional surgical devices such as catheters and guidewires, as well as stents and other implants that can be safely and effectively imaged under MRI. The technology is also being used to create enhanced MRI contrast agents. Committed to growth through innovation and developmental leadership, Biophan and its licensors have nine issued U.S. patents and over fifty patents pending, in areas including nanotechnology (nanomagnetic particle coatings), radio frequency filters, polymer composites, and photonics. Biophan's technology will help realize its goal of one day making all biomedical devices capable of safely and successfully working with MRI. For more information, please visit www.biophan.com.
About TE-Bio
TE-Bio holds an exclusive license to a patented innovation for generating power for an implantable medical device using thermoelectric materials. The technology is applicable to a wide variety of devices from biosensors to cardioverter defibrillators. TE-Bio is a limited liability company owned 51% by Biophan Technologies, Inc., and 49% by Biomed Solutions, LLC. The company is developing the thermoelectric materials and related circuits, and will provide these devices to biomedical device manufacturers and battery companies on an OEM basis.
Cautionary Statement Regarding Forward-Looking Statements
Certain statements included in this press release may constitute forward-looking statements. Actual results could differ materially from such statements expressed or implied herein as a result of a variety of factors including, but not limited to: the development of Biophan's MRI technologies; the approval of Biophan's patent applications; the successful implementation of Biophan's research and development programs; the acceptance by the market of Biophan's products; competition and the timing of projects and trends in future operating performance, as well as other factors expressed from time to time in Biophan's periodic filings with the Securities and Exchange Commission (the "SEC"). As a result, this press release should be read in conjunction with Biophan's periodic filings with the SEC. The forward-looking statements contained herein are made only as of the date of this press release, and Biophan undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.
SOURCE: Biophan Technologies, Inc.
Copyright (C) 2004 Business Wire. All rights reserved.
Biophan Announces Development of Breakthrough Long-Life Biothermal Battery
5/14/2004 4:01:00 PM
Company Acquires Majority Interest in Biothermal Battery Nanotechnology Venture Targeting Approximately $500 Million Global Market
ROCHESTER, N.Y., May 14, 2004 (BUSINESS WIRE) -- Biophan Technologies, Inc. ( BIPH ), a leading developer of next generation biomedical technology, announced today that it has acquired a majority interest in TE-Bio, LLC, a company developing a breakthrough, long-life power source for use in implanted medical devices, such as pacemakers, defibrillators, neurostimulators, and drug pumps.
The technology is based on a patented innovation in the utilization of thermoelectric materials, using nanoscale-based, thin-film materials to convert thermal energy produced naturally by the human body into electrical energy. The resulting power can be used to "trickle charge" batteries for medium-power devices such as defibrillators, or directly power low-energy devices like pacemakers. The Company will be displaying the technology to over 6,000 healthcare professionals at the NASPE--Heart Rhythm Society's Heart Rhythm 2004 Conference, May 19-22, 2004 in San Francisco, CA.
TE-Bio is developing an implantable power system that has the potential to provide as much as a 30-year life--a five-fold increase in service life compared to existing technology. The technology is anticipated to dramatically extend the service life of neurostimulators and drug pumps that are used for treatment of tremors, diabetes, and chronic pain. Furthermore, since these devices can be implanted in young patients, the combination of TE-Bio technology and extended device life may reduce the number of replacement implants needed throughout a patient's life. For further information or to view the patent, please visit www.biophan.com/biothermal.php.
The use of implantable electronic medical devices is increasing worldwide due, in part, to the aging of the population and the increased use of these devices for both diagnostic and therapeutic treatments. However, existing systems share a major shortcoming - the need for a reliable electrical power source that does not require periodic surgical removal and replacement. Virtually all medical devices require replacement. It is estimated that neurostimulators, used to treat Parkinson's disease, last an average of three years; defibrillators last about five to six years, and pacemakers an average of about eight years.
Thermoelectric materials are special types of semiconductors that produce electricity when one side of the material is heated and the other is cooled. These materials have been used to generate electricity on spacecraft, such as the Voyager space probe, that are too far away from the sun for solar cells to operate. However, the low energy efficiency of existing materials has required very large temperature differences to produce a sufficient amount of usable power.
Recent advances in nanotechnology have now made new thermoelectric materials with the potential for generating sufficient electrical power for implantable medical devices, in part due to the ability to produce many more semiconductors on a surface.
TE-Bio holds a worldwide exclusive license to patent #6,640,137 "Biothermal Power Source for Implantable Devices" from Biomed Solutions, LLC.
"The realization of generating enough energy to power a pacemaker, or extend the life of a defibrillator, from the heat differential in our bodies, has been brought within striking distance by the remarkable revolution in materials science and advances in nanotechnology," stated Michael Weiner, CEO of Biophan.
Conference Call and Webcast
The Company will discuss the impact and market opportunity represented by this breakthrough technology on a conference call and webcast on Tuesday, May 18 at 12:00 pm Eastern. Following the discussion, Michael Weiner, president of Biophan, and other members of the executive management team will be available to answer questions regarding the technology and other technology which the Company is currently developing. Participants may ask questions during the Q & A segment of the call or, if they prefer, may e-mail questions in advance of the call to Randy Lewis, senior vice president of Trilogy Capital Partners, randy@trilogy-capital.com. To access the call, Investors should call at (888) 423-3274, code 731878 or from an international location by calling (651) 291-0278.
About Biophan Technologies
Biophan Technologies develops and markets cutting-edge technologies designed to make biomedical devices--such as cardiac pacemakers, surgical and diagnostic tools--safe and compatible with magnetic resonance imaging (MRI) equipment. The Company develops enabling technologies for implanted medical systems such as pacemakers, and interventional surgical devices such as catheters and guidewires, as well as stents and other implants that can be safely and effectively imaged under MRI. The technology is also being used to create enhanced MRI contrast agents. Committed to growth through innovation and developmental leadership, Biophan and its licensors have nine issued U.S. patents and over fifty patents pending, in areas including nanotechnology (nanomagnetic particle coatings), radio frequency filters, polymer composites, and photonics. Biophan's technology will help realize its goal of one day making all biomedical devices capable of safely and successfully working with MRI. For more information, please visit www.biophan.com.
About TE-Bio
TE-Bio holds an exclusive license to a patented innovation for generating power for an implantable medical device using thermoelectric materials. The technology is applicable to a wide variety of devices from biosensors to cardioverter defibrillators. TE-Bio is a limited liability company owned 51% by Biophan Technologies, Inc., and 49% by Biomed Solutions, LLC. The company is developing the thermoelectric materials and related circuits, and will provide these devices to biomedical device manufacturers and battery companies on an OEM basis.
Cautionary Statement Regarding Forward-Looking Statements
Certain statements included in this press release may constitute forward-looking statements. Actual results could differ materially from such statements expressed or implied herein as a result of a variety of factors including, but not limited to: the development of Biophan's MRI technologies; the approval of Biophan's patent applications; the successful implementation of Biophan's research and development programs; the acceptance by the market of Biophan's products; competition and the timing of projects and trends in future operating performance, as well as other factors expressed from time to time in Biophan's periodic filings with the Securities and Exchange Commission (the "SEC"). As a result, this press release should be read in conjunction with Biophan's periodic filings with the SEC. The forward-looking statements contained herein are made only as of the date of this press release, and Biophan undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.
SOURCE: Biophan Technologies, Inc.
Copyright (C) 2004 Business Wire. All rights reserved.
wow, below .002 whoduhthunkit?
seho on watch
still hangin. cded plkc gzfx ibzt biph agrd. you?
one to watch closely.
thanks TRST, i think youre right.